Record Information |
---|
Version | 5.0 |
---|
Status | Detected but not Quantified |
---|
Creation Date | 2021-09-11 22:57:35 UTC |
---|
Update Date | 2021-09-26 23:17:49 UTC |
---|
HMDB ID | HMDB0259953 |
---|
Secondary Accession Numbers | None |
---|
Metabolite Identification |
---|
Common Name | 6-Imidazol-1-yl-7-nitro-1,4-dihydroquinoxaline-2,3-dione |
---|
Description | 6-(1H-imidazol-1-yl)-7-nitro-1,2,3,4-tetrahydroquinoxaline-2,3-dione belongs to the class of organic compounds known as quinoxalines. Quinoxalines are compounds containing a quinoxaline moiety, a bicyclic heterocycle made up of a benzene ring fused to a pyrazine ring. Based on a literature review very few articles have been published on 6-(1H-imidazol-1-yl)-7-nitro-1,2,3,4-tetrahydroquinoxaline-2,3-dione. This compound has been identified in human blood as reported by (PMID: 31557052 ). 6-imidazol-1-yl-7-nitro-1,4-dihydroquinoxaline-2,3-dione is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically 6-Imidazol-1-yl-7-nitro-1,4-dihydroquinoxaline-2,3-dione is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
---|
Structure | [O-][N+](=O)C1=C(C=C2NC(=O)C(=O)NC2=C1)N1C=CN=C1 InChI=1S/C11H7N5O4/c17-10-11(18)14-7-4-9(16(19)20)8(3-6(7)13-10)15-2-1-12-5-15/h1-5H,(H,13,17)(H,14,18) |
---|
Synonyms | Value | Source |
---|
6-(1H-Imidazol-1-yl)-7-nitro-2,3(1H,4H)-quinoxalinedione | MeSH | YM 90K | MeSH | YM-90K | MeSH | YM90K | MeSH |
|
---|
Chemical Formula | C11H7N5O4 |
---|
Average Molecular Weight | 273.208 |
---|
Monoisotopic Molecular Weight | 273.049803725 |
---|
IUPAC Name | 6-(1H-imidazol-1-yl)-7-nitro-1,2,3,4-tetrahydroquinoxaline-2,3-dione |
---|
Traditional Name | 6-(imidazol-1-yl)-7-nitro-1,4-dihydroquinoxaline-2,3-dione |
---|
CAS Registry Number | Not Available |
---|
SMILES | [O-][N+](=O)C1=C(C=C2NC(=O)C(=O)NC2=C1)N1C=CN=C1 |
---|
InChI Identifier | InChI=1S/C11H7N5O4/c17-10-11(18)14-7-4-9(16(19)20)8(3-6(7)13-10)15-2-1-12-5-15/h1-5H,(H,13,17)(H,14,18) |
---|
InChI Key | GBWIZNYOJITVFI-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as quinoxalines. Quinoxalines are compounds containing a quinoxaline moiety, a bicyclic heterocycle made up of a benzene ring fused to a pyrazine ring. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Diazanaphthalenes |
---|
Sub Class | Benzodiazines |
---|
Direct Parent | Quinoxalines |
---|
Alternative Parents | |
---|
Substituents | - Quinoxaline
- Nitroaromatic compound
- N-substituted imidazole
- Pyrazine
- Benzenoid
- Azole
- Imidazole
- Heteroaromatic compound
- Lactam
- C-nitro compound
- Organic nitro compound
- Azacycle
- Organic oxoazanium
- Organic 1,3-dipolar compound
- Propargyl-type 1,3-dipolar organic compound
- Allyl-type 1,3-dipolar organic compound
- Organooxygen compound
- Organonitrogen compound
- Organic nitrogen compound
- Organic salt
- Organic oxygen compound
- Organic zwitterion
- Organic oxide
- Hydrocarbon derivative
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
6-Imidazol-1-yl-7-nitro-1,4-dihydroquinoxaline-2,3-dione,1TMS,isomer #1 | C[Si](C)(C)N1C(=O)C(=O)[NH]C2=CC([N+](=O)[O-])=C(N3C=CN=C3)C=C21 | 2790.4 | Semi standard non polar | 33892256 | 6-Imidazol-1-yl-7-nitro-1,4-dihydroquinoxaline-2,3-dione,1TMS,isomer #1 | C[Si](C)(C)N1C(=O)C(=O)[NH]C2=CC([N+](=O)[O-])=C(N3C=CN=C3)C=C21 | 2960.7 | Standard non polar | 33892256 | 6-Imidazol-1-yl-7-nitro-1,4-dihydroquinoxaline-2,3-dione,1TMS,isomer #1 | C[Si](C)(C)N1C(=O)C(=O)[NH]C2=CC([N+](=O)[O-])=C(N3C=CN=C3)C=C21 | 3968.6 | Standard polar | 33892256 | 6-Imidazol-1-yl-7-nitro-1,4-dihydroquinoxaline-2,3-dione,1TMS,isomer #2 | C[Si](C)(C)N1C(=O)C(=O)[NH]C2=CC(N3C=CN=C3)=C([N+](=O)[O-])C=C21 | 2772.2 | Semi standard non polar | 33892256 | 6-Imidazol-1-yl-7-nitro-1,4-dihydroquinoxaline-2,3-dione,1TMS,isomer #2 | C[Si](C)(C)N1C(=O)C(=O)[NH]C2=CC(N3C=CN=C3)=C([N+](=O)[O-])C=C21 | 2954.4 | Standard non polar | 33892256 | 6-Imidazol-1-yl-7-nitro-1,4-dihydroquinoxaline-2,3-dione,1TMS,isomer #2 | C[Si](C)(C)N1C(=O)C(=O)[NH]C2=CC(N3C=CN=C3)=C([N+](=O)[O-])C=C21 | 3953.2 | Standard polar | 33892256 | 6-Imidazol-1-yl-7-nitro-1,4-dihydroquinoxaline-2,3-dione,2TMS,isomer #1 | C[Si](C)(C)N1C(=O)C(=O)N([Si](C)(C)C)C2=CC([N+](=O)[O-])=C(N3C=CN=C3)C=C21 | 2836.2 | Semi standard non polar | 33892256 | 6-Imidazol-1-yl-7-nitro-1,4-dihydroquinoxaline-2,3-dione,2TMS,isomer #1 | C[Si](C)(C)N1C(=O)C(=O)N([Si](C)(C)C)C2=CC([N+](=O)[O-])=C(N3C=CN=C3)C=C21 | 3077.2 | Standard non polar | 33892256 | 6-Imidazol-1-yl-7-nitro-1,4-dihydroquinoxaline-2,3-dione,2TMS,isomer #1 | C[Si](C)(C)N1C(=O)C(=O)N([Si](C)(C)C)C2=CC([N+](=O)[O-])=C(N3C=CN=C3)C=C21 | 3525.4 | Standard polar | 33892256 | 6-Imidazol-1-yl-7-nitro-1,4-dihydroquinoxaline-2,3-dione,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N1C(=O)C(=O)[NH]C2=CC([N+](=O)[O-])=C(N3C=CN=C3)C=C21 | 2943.6 | Semi standard non polar | 33892256 | 6-Imidazol-1-yl-7-nitro-1,4-dihydroquinoxaline-2,3-dione,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N1C(=O)C(=O)[NH]C2=CC([N+](=O)[O-])=C(N3C=CN=C3)C=C21 | 3164.2 | Standard non polar | 33892256 | 6-Imidazol-1-yl-7-nitro-1,4-dihydroquinoxaline-2,3-dione,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N1C(=O)C(=O)[NH]C2=CC([N+](=O)[O-])=C(N3C=CN=C3)C=C21 | 3935.2 | Standard polar | 33892256 | 6-Imidazol-1-yl-7-nitro-1,4-dihydroquinoxaline-2,3-dione,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N1C(=O)C(=O)[NH]C2=CC(N3C=CN=C3)=C([N+](=O)[O-])C=C21 | 2934.8 | Semi standard non polar | 33892256 | 6-Imidazol-1-yl-7-nitro-1,4-dihydroquinoxaline-2,3-dione,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N1C(=O)C(=O)[NH]C2=CC(N3C=CN=C3)=C([N+](=O)[O-])C=C21 | 3156.8 | Standard non polar | 33892256 | 6-Imidazol-1-yl-7-nitro-1,4-dihydroquinoxaline-2,3-dione,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N1C(=O)C(=O)[NH]C2=CC(N3C=CN=C3)=C([N+](=O)[O-])C=C21 | 3924.7 | Standard polar | 33892256 | 6-Imidazol-1-yl-7-nitro-1,4-dihydroquinoxaline-2,3-dione,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N1C(=O)C(=O)N([Si](C)(C)C(C)(C)C)C2=CC([N+](=O)[O-])=C(N3C=CN=C3)C=C21 | 3153.6 | Semi standard non polar | 33892256 | 6-Imidazol-1-yl-7-nitro-1,4-dihydroquinoxaline-2,3-dione,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N1C(=O)C(=O)N([Si](C)(C)C(C)(C)C)C2=CC([N+](=O)[O-])=C(N3C=CN=C3)C=C21 | 3493.7 | Standard non polar | 33892256 | 6-Imidazol-1-yl-7-nitro-1,4-dihydroquinoxaline-2,3-dione,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N1C(=O)C(=O)N([Si](C)(C)C(C)(C)C)C2=CC([N+](=O)[O-])=C(N3C=CN=C3)C=C21 | 3540.8 | Standard polar | 33892256 |
|
---|